CPHI Japan 2020 Postponed

Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.

The decision was taken after many of the event’s largest stakeholders – international exhibitors and major pharmaceutical employees – reported that they would be unable to travel to the exhibition at this time.

“The event is now in its 18th edition and we have always listened to the feedback of our exhibitors and attendees. Due to unforeseen circumstances of COVID-19, many felt that it will be difficult to travel to the exhibition at this time. We will work with our attendees and exhibitors so that we can deliver another successful event for everyone involved. We wanted to communicate this as fast as possible, and we will confirm the new dates imminently. I thank our partners for their continued support and understanding, and we express our solidarity with those affected around the world,” commented Christopher Eve, Managing Director, Informa Markets and UBM Japan.